The University of Oxford and its vaccine production partner AstraZeneca announced positive high-level results from an initial analysis of clinical trials of the experimental vaccine candidate, AZD1222.
Read More
![](https://covid19.healthcare.pro/wp-content/uploads/2020/11/london-3078109.jpg)
The University of Oxford and its vaccine production partner AstraZeneca announced positive high-level results from an initial analysis of clinical trials of the experimental vaccine candidate, AZD1222.
Read More